Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.

As the focus on evidence-based decision-making in healthcare has increased, the role and scope of Health Technology Assessment (HTA) has evolved. The rising number of new pharmaceuticals, medical devices, and other health innovations, along with their novelty and increasing complexity, have led to an increased demand for assessment. How evidence synthesis fits in with Cost Effectiveness Analysis and Budget Impact Assessment and their current challenges with literature review use to support HTAs is discussed.

Key Topics Include:

  • Ensuring speed, accuracy and quality while dealing with information overload and time constraints.
  • Employing automation to improve literature reviews and processes.
  • The relevance of evidence synthesis.
  • What is admissible in terms of AI-enabled technologies for assessments?

Resources

Presenters

Director
Consulting Operations
Maple Health Group, LLC

Dr. Chris Waters-Banker is a consultant at Maple Health Group with over a decade of experience in clinical scientific research. She has extensive knowledge in health research methodology across both basic and applied clinical sciences, with expertise in musculoskeletal conditions and immunology.

Assistant Director
Evidence Synthesis & Modeling
Xcenda

Maria Arregui, PhD, is an Assistant Director on the HTA Reviews team at Xcenda. In this role, she supports literature reviews aimed at understanding the clinical and economic burden of disease and helps manufacturers prepare for regulatory and reimbursement submissions using systematic literature review (SLR) and network meta-analysis (NMA) techniques.

Associate Director
Curta Inc.

Dr. Rajshree Pandey is an Associate Director at Curta Inc and serves as the evidence synthesis lead. She has extensive experience in evidence synthesis methods including systematic literature reviews, indirect treatment comparisons, and public health research.

Account Executive
DistillerSR

Lee-Anne Bourke is a librarian with a keen interest in bibliometric trends, literature review methodologies and information management. She joined Evidence Partners in 2021 as an Account Executive. She is passionate about research and is a published author of Cochrane, Campbell and JBI systematic reviews.

President & Founder
The Peeples Collaborative

Patti is a health economist, pharmacist and industry leader with 35 years of experience in health care value, evidence and access.

Production Partner

DistillerSR

DistillerSR automates every stage of the systematic review process for faster and more accurate evidence-based research. More than 300 of the world’s leading pharmaceutical and medical device companies, contract research organizations, governments, NGOs, and academic institutions trust DistillerSR to achieve transparent, audit-ready, and compliant literature reviews.

Additional Content From DistillerSR

Additional Content From HealthEconomics.Com

Social Media Data: Opportunities and Insights for Clinical Research

Social Media Data: Opportunities and Insights for Clinical Research

Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts. These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.

Related Content